Fast Responders (1 to 2 weeks): The majority of positive experiences fall into this category
References: Seiwerth, S., Milavic, M., Vukojevic, J., Gojkovic, S., Krezic, I., Vuletic, L
Najbolji deo je da BPC-157 ne dolazi s nepovoljnim nuspojavama
Short non-diabetic data support remaining at 2.5 mg when weight and insulin-resistance markers are already moving and tolerability favors a hold. The label still positions 2.5 mg as the starter before 5 mg, so it is a defensible low-dose floor for selected users rather than a replacement for the 5 mg obesity-trial floor
Small sample sizes can make drugs look much more or less effective than what they really are